New Risk • Jun 29
New minor risk - Market cap size The company's market capitalization is less than US$100m. Market cap: AU$144.0m (US$99.4m) This is considered a minor risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risk Revenue is less than US$1m (AU$1.2m revenue, or US$855k). Minor Risk Market cap is less than US$100m (AU$144.0m market cap, or US$99.4m). Reported Earnings • Mar 16
First half 2026 earnings released: AU$0.002 loss per share (vs AU$0.001 loss in 1H 2025) First half 2026 results: AU$0.002 loss per share (further deteriorated from AU$0.001 loss in 1H 2025). Net loss: AU$3.24m (loss widened 192% from 1H 2025). Revenue is forecast to grow 52% p.a. on average during the next 3 years, compared to a 7.9% growth forecast for the Metals and Mining industry in Australia. Over the last 3 years on average, earnings per share has fallen by 14% per year but the company’s share price has increased by 4% per year, which means it is well ahead of earnings. New Risk • Mar 04
New minor risk - Market cap size The company's market capitalization is less than US$100m. Market cap: AU$139.9m (US$99.0m) This is considered a minor risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risk Revenue is less than US$1m (AU$966k revenue, or US$683k). Minor Risk Market cap is less than US$100m (AU$139.9m market cap, or US$99.0m). Anuncio • Oct 03
Zeotech Limited, Annual General Meeting, Nov 28, 2025 Zeotech Limited, Annual General Meeting, Nov 28, 2025. Reported Earnings • Oct 01
Full year 2025 earnings released: AU$0.002 loss per share (vs AU$0.003 loss in FY 2024) Full year 2025 results: AU$0.002 loss per share (improved from AU$0.003 loss in FY 2024). Net loss: AU$4.41m (loss narrowed 20% from FY 2024). Over the last 3 years on average, earnings per share has fallen by 3% per year but the company’s share price has increased by 34% per year, which means it is well ahead of earnings. Anuncio • Sep 30
Zeotech Limited has completed a Follow-on Equity Offering in the amount of AUD 13 million. Zeotech Limited has completed a Follow-on Equity Offering in the amount of AUD 13 million.
Security Name: Ordinary Shares
Security Type: Common Stock
Securities Offered: 162,500,000
Price\Range: AUD 0.08
Discount Per Security: AUD 0.0056
Transaction Features: Subsequent Direct Listing New Risk • Sep 28
New minor risk - Financial data availability The company's latest financial reports are more than 6 months old. Last reported fiscal period ended December 2024. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-AU$1.8m free cash flow). Earnings have declined by 13% per year over the past 5 years. Revenue is less than US$1m (AU$977k revenue, or US$640k). Minor Risk Latest financial reports are more than 6 months old (reported December 2024 fiscal period end). Anuncio • Mar 31
Zeotech Limited Appoints Shane Graham as an Executive Director (Technical), Effective April 7, 2025 Zeotech Limited announced that the appointment of experienced building materials and construction technology executive Mr. Shane Graham as an Executive Director (Technical), effective April 7. Mr. Graham is a high-performing business leader with over 30 years of extensive experience in the building materials sector. This includes executive management roles with two of Australia's leading building materials companies, including 5 years at Holcim (Australia) Pty Limited ("Holcim") and over 20 years at Boral Limited ("Boral"). At Holcim, he held the positions of Executive General Manager Commercial & Major Projects in this role he was responsible for securing Major Infrastructure project opportunities and Executive General Manager of Humes Australia. Prior to joining Holcim, he held various Executive General Management roles at Boral, including Executive General Manager Queensland with National oversight of Boral Concrete, before progressing to the position of Executive General Manager Major Projects & Project Management Office. In this role, Mr. Graham was responsible for securing major construction projects and maintaining senior relationships with all major national and international contractors. Furthermore, Mr. Graham has experience leading a resources and infrastructure services group that provided civil contracting, mining services, construction materials, transport, and bulk haulage services. Reported Earnings • Mar 15
First half 2025 earnings released: AU$0.001 loss per share (vs AU$0.002 loss in 1H 2024) First half 2025 results: AU$0.001 loss per share (improved from AU$0.002 loss in 1H 2024). Net loss: AU$1.11m (loss narrowed 71% from 1H 2024). Over the last 3 years on average, earnings per share has fallen by 4% per year whereas the company’s share price has fallen by 9% per year. New Risk • Mar 12
New major risk - Financial position The company has less than a year of cash runway based on its current free cash flow trend. Free cash flow: -AU$1.8m This is considered a major risk. With less than a year's worth of cash, the company will need to raise capital or take on debt unless its cash flows improve. This would dilute existing shareholders or increase balance sheet risk. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-AU$1.8m free cash flow). Earnings have declined by 13% per year over the past 5 years. Revenue is less than US$1m (AU$977k revenue, or US$615k). Minor Risk Market cap is less than US$100m (AU$76.0m market cap, or US$47.9m). Anuncio • Oct 04
Zeotech Limited, Annual General Meeting, Nov 22, 2024 Zeotech Limited, Annual General Meeting, Nov 22, 2024. Reported Earnings • Sep 28
Full year 2024 earnings released: AU$0.003 loss per share (vs AU$0.002 loss in FY 2023) Full year 2024 results: AU$0.003 loss per share (further deteriorated from AU$0.002 loss in FY 2023). Net loss: AU$5.53m (loss widened 124% from FY 2023). Over the last 3 years on average, earnings per share has fallen by 12% per year but the company’s share price has fallen by 28% per year, which means it is performing significantly worse than earnings. Recent Insider Transactions Derivative • Mar 28
MD & Director exercised options and sold AU$232k worth of stock On the 27th of March, Peter Zardo exercised 20.00m options to receive shares at no cost, then sold 20m of them for an average price of -AU$0.012 per share and kept the remainder. Since June 2023, Peter has owned 57.81m shares directly. Company insiders have collectively bought AU$188k more than they sold, via options and on-market transactions, in the last 12 months. Reported Earnings • Mar 15
First half 2024 earnings released: AU$0.002 loss per share (vs AU$0 in 1H 2023) First half 2024 results: AU$0.002 loss per share (further deteriorated from AU$0 in 1H 2023). Net loss: AU$3.84m (loss widened 452% from 1H 2023). Over the last 3 years on average, earnings per share has increased by 4% per year but the company’s share price has fallen by 28% per year, which means it is significantly lagging earnings. New Risk • Mar 14
New major risk - Financial position The company has less than a year of cash runway based on its current free cash flow trend. Free cash flow: -AU$2.6m This is considered a major risk. With less than a year's worth of cash, the company will need to raise capital or take on debt unless its cash flows improve. This would dilute existing shareholders or increase balance sheet risk. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-AU$2.6m free cash flow). Share price has been highly volatile over the past 3 months (19% average weekly change). Earnings have declined by 25% per year over the past 5 years. Revenue is less than US$1m (AU$755k revenue, or US$500k). Minor Risks Shareholders have been diluted in the past year (5.7% increase in shares outstanding). Market cap is less than US$100m (AU$50.3m market cap, or US$33.3m). New Risk • Feb 20
New major risk - Share price stability The company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Australian stocks, typically moving 17% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (17% average weekly change). Earnings have declined by 23% per year over the past 5 years. Revenue is less than US$1m (AU$1.1m revenue, or US$701k). Minor Risks Shareholders have been diluted in the past year (5.7% increase in shares outstanding). Significant insider selling over the past 3 months (AU$82k sold). Market cap is less than US$100m (AU$43.3m market cap, or US$28.3m). Recent Insider Transactions • Nov 24
Insider recently sold AU$82k worth of stock On the 21st of November, John Goody sold around 2m shares on-market at roughly AU$0.041 per share. This transaction amounted to 2.1% of their direct individual holding at the time of the trade. This was the largest sale by an insider in the last 3 months. Insiders have been net sellers, collectively disposing of AU$218k more than they bought in the last 12 months. New Risk • Nov 13
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Australian stocks, typically moving 12% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Earnings have declined by 23% per year over the past 5 years. Revenue is less than US$1m (AU$1.1m revenue, or US$684k). Minor Risks Share price has been volatile over the past 3 months (12% average weekly change). Shareholders have been diluted in the past year (7.1% increase in shares outstanding). Market cap is less than US$100m (AU$89.9m market cap, or US$57.3m). Anuncio • Oct 05
Zeotech Limited, Annual General Meeting, Nov 23, 2023 Zeotech Limited, Annual General Meeting, Nov 23, 2023. Reported Earnings • Sep 21
Full year 2023 earnings released: AU$0.002 loss per share (vs AU$0.003 loss in FY 2022) Full year 2023 results: AU$0.002 loss per share (improved from AU$0.003 loss in FY 2022). Net loss: AU$2.47m (loss narrowed 42% from FY 2022). Over the last 3 years on average, earnings per share has increased by 19% per year but the company’s share price has increased by 58% per year, which means it is tracking significantly ahead of earnings growth. New Risk • Sep 10
New minor risk - Financial data availability The company's latest financial reports are more than 6 months old. Last reported fiscal period ended December 2022. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-AU$4.3m free cash flow). Earnings have declined by 28% per year over the past 5 years. Revenue is less than US$1m (AU$1.1m revenue, or US$670k). Minor Risks Latest financial reports are more than 6 months old (reported December 2022 fiscal period end). Shareholders have been diluted in the past year (9.2% increase in shares outstanding). Market cap is less than US$100m (AU$80.2m market cap, or US$51.1m). Recent Insider Transactions • Mar 17
MD, COO & Director recently sold AU$135k worth of stock On the 15th of March, Peter Zardo sold around 2m shares on-market at roughly AU$0.057 per share. This transaction amounted to 3.9% of their direct individual holding at the time of the trade. This was the largest sale by an insider in the last 3 months. This was Peter's only on-market trade for the last 12 months. Reported Earnings • Mar 11
First half 2023 earnings released: EPS: AU$0 (vs AU$0.001 loss in 1H 2022) First half 2023 results: EPS: AU$0 (improved from AU$0.001 loss in 1H 2022). Net loss: AU$694.5k (loss narrowed 69% from 1H 2022). Over the last 3 years on average, earnings per share has increased by 2% per year but the company’s share price has increased by 128% per year, which means it is tracking significantly ahead of earnings growth. Anuncio • Dec 14
Zeotech Limited Appoints Alister Morrison as Chief Executive Officer, Effective 13 March 2023 Zeotech Limited announced that Mr. Alister Morrison (MSc, GAICD, ACEcD) has been appointed as Chief Executive Officer (CEO), effective 13 March 2023. Morrison is an accomplished senior executive with 25-years of strategic international experience, mainly across the energy, natural resources and early-stage technology commercialisation sectors. He has worked for a range of organizations including US and UK listed companies and has a track record in raising capital, mergers and acquisitions (M&A), building and managing high performance teams, developing technical assets and driving corporate growth. Prior to joining Zeotech, Mr. Morrison will have spent approximately five years at UniQuest, the University of Queensland's ("UQ") main commercialisation company, as Senior Director & Head of Physical Sciences, based in Brisbane, Australia. During his time at UniQuest, he led the initial commercialisation of the Company's proprietary mineral processing innovation and maintained contractual management oversight of the main research programs undertaken at UQ, and in doing so acquired an intimate understanding of Zeotech's core intellectual property (IP), technology development roadmap, and ongoing commercialisation pathway. Recent Insider Transactions Derivative • Dec 02
MD, COO & Director exercised options to buy AU$490k worth of stock. On the 28th of November, Peter Zardo exercised options to buy 10m shares at a strike price of around AU$0.036, costing a total of AU$360k. This transaction amounted to 23% of their direct individual holding at the time of the trade. Since December 2021, Peter has owned 43.38m shares directly. Company insiders have collectively bought AU$89k more than they sold, via options and on-market transactions, in the last 12 months. Anuncio • Nov 28
Zeotech Limited Announces Successful Completion of Pilot Program Accelerates Technology Development Zeotech Limited advised it has successfully concluded the pilot plant ("Pilot") research program for its novel and proprietary mineral processing technology with The University of Queensland ("UQ") School of Chemical Engineering and UniQuest, UQ's commercialisation company. The Pilot has been in operation at UQ since February 2021 and has achieved its principal objectives by demonstrating a continuous closed-loop circuit from lithium process by- product (leached spodumene) and kaolin feedstock options, providing important process validation of the patent-pending technology. HIGHLIGHTS: Pilot research program successfully completed for novel and proprietary mineral processing technology with UQ and UniQuest The Pilot has provided important validation for the Company's mineral processing innovation by demonstrating multiple continuous closed-loop circuits from dual feedstock options Recent performance runs and process optimisation has generated over 20kg of manufactured zeolite product Development will now be accelerated under two parallel work streams: Technology associated with lithium process by-product to be advanced by the Resources Technology and Critical Minerals Processing Trailblazer Program ("Trailblazer"). Development of the technology from kaolin feedstock will be undertaken at the Company's recently established lab facility at Brisbane Technology Park, following commissioning of a scaled-up in-house Pilot. Preparation of product specification and safety data sheets for Zeotech's manufactured zeolite products are well advanced, and will support marketing activity when providing manufactured zeolite product samples to potential offtake or joint venture partners. Board Change • Nov 16
No independent directors Following the recent departure of a director, there are no independent directors on the board. The company's board is composed of: No independent directors. 3 non-independent directors. Non-Executive Chairman Sylvia Tulloch was the last director to join the board, commencing their role in 2020. The company's lack of independent directors is a risk according to the Simply Wall St Risk Model. Anuncio • Oct 04
Zeotech Limited, Annual General Meeting, Nov 28, 2022 Zeotech Limited, Annual General Meeting, Nov 28, 2022. Reported Earnings • Sep 21
Full year 2022 earnings released: AU$0.003 loss per share (vs AU$0.002 loss in FY 2021) Full year 2022 results: AU$0.003 loss per share (further deteriorated from AU$0.002 loss in FY 2021). Net loss: AU$4.23m (loss widened 45% from FY 2021). Over the last 3 years on average, earnings per share has fallen by 18% per year but the company’s share price has increased by 55% per year, which means it is well ahead of earnings. Anuncio • Jul 28
Zeotech Limited, Annual General Meeting, Aug 31, 2022 Zeotech Limited, Annual General Meeting, Aug 31, 2022, at 14:00 E. Australia Standard Time. Location: Hyatt Hotel Canberra, 120 Commonwealth Ave, Yarralumla, ACT 2600 Yarrabah Australia Agenda: General Meeting of Shareholders. Anuncio • May 31
Zeotech Limited Achieves Successful Continuous Closed- Loop Circuit, Utilising Lithium Process By-Product Feedstock (Leached Spodumene) to Produce Pure Linde Type A Manufactured Zeolite Zeotech Limited advised that it has achieved a successful continuous closed- loop circuit, utilising lithium process by-product feedstock (leached spodumene) to produce pure Linde Type A manufactured zeolite. This demonstration of the Company's dual-feed pilot is a significant milestone in the program with both leached spodumene and kaolin feedstock options being processed through the circuit. The achievement of multiple closed-looped circuit runs utilising lithium process by-product provides important validation of the Company's proprietary flowsheet and will allow personnel from The University of Queensland ("UQ") and the Company to commence project planning for The Trailblazer University Program ("Trailblazer"), which includes industry partner, Covalent Lithium Pty Limited. Since receiving (new) leached spodumene samples in December 2021, UQ researchers have completed over 80 optimisation batch tests and 25 continuous tests completed on individual process steps, involving leaching, filtration/decanting, and precipitation. The pilot has produced over 3 kgs of pure Linde Type A manufactured zeolite product utilising lithium process by-product as feedstock. The pilot program's focus on lithium process by-product delivered an excellent outcome, highlighted by the Company being named as an industry partner in the successful Resources Technology and Critical Minerals Processing Trailblazer Program, led by Curtin University 2 in April 2022. The Trailblazer project will accelerate the commercialisation of Zeotech's proprietary cleantech innovation for lithium process by-product in collaboration with project partners, UQ and Covalent. The Trailblazer grant program provides Federal Government funding to select universities to boost prioritised research and development and drive commercialisation outcomes with industry partners. Next Steps: The completion of a successful continuous closed-loop circuit under the conditions of Zeotech's proprietary flowsheet represents a major step in accelerating Trailblazer planning, with the project's objective of constructing and commissioning a large-scale demonstration plant. Focus on the Company's dual-feed pilot program will remain on lithium process by-product until end of June 2022, in conjunction with commencement of Trailblazer project planning. Attention will then return to kaolin feedstock in early July 2022, following a successful continuous closed-loop circuit utilising Toondoon kaolin feedstock in November 2021. Board Change • Apr 27
No independent directors Following the recent departure of a director, there are no independent directors on the board. The company's board is composed of: No independent directors. 3 non-independent directors. Non-Executive Chairman Sylvia Tulloch was the last director to join the board, commencing their role in 2020. The company's lack of independent directors is a risk according to the Simply Wall St Risk Model. Reported Earnings • Mar 08
First half 2022 earnings: Revenues and EPS in line with analyst expectations First half 2022 results: AU$0.001 loss per share (vs AU$0.001 loss in 1H 2021). Net loss: AU$2.22m (loss widened 32% from 1H 2021). Revenue was in line with analyst estimates. Over the last 3 years on average, earnings per share has fallen by 11% per year but the company’s share price has increased by 114% per year, which means it is well ahead of earnings. Anuncio • Feb 24
Zeotech Limited to Be Deleted from Other OTC Zeotech Limited's ordinary shares (Australia) will be deleted from Other OTC effective February 23, 2022. The deletion is due to Inactive Security. Anuncio • Nov 30
Zeotech Limited Announces Pilot Program Update Zeotech Limited announced that it has successfully completed its first continuous closed-loop circuit, utilising kaolin feedstock to produce pure Linde Type A synthetic zeolite product. This marks a significant step in progressing the Company's dual-feed pilot program. Successful bench-scale continuous closed-loop circuit achieved utilising kaolin feedstock to produce pure Linde Type A synthetic zeolite product. Over 110 optimisation batch tests undertaken using Toondoon kaolin and Li process by-product samples, undertaken since May 2021. Over 30 continuous tests completed on individual process steps, involving leaching, filtration/decanting, and precipitation. Plant and equipment procurement underway, with construction and commissioning of pilot plant on track to commence early First Quarter 2022. During the H2 2021, the team at UQ completed in excess of 155 batch and continuous test runs. This work, together with the earlier start date on kaolin test-work, has led to successful development of the first continuous closed-loop circuit utilising Toondoon kaolin as feedstock to produce pure Linde Type A synthetic zeolite product. Since June 2021, UQ researchers have completed over 70 optimisation batch tests across a range leaching and precipitation configurations from two separate samples of Li process by- product. Continuous tank reactor precipitation work has been successfully completed and the team is currently undertaking continuous leaching runs. The inclusion of two separate Li process by-product samples to the pilot program, has increased the variables in validating ZEO's proprietary flowsheet process steps. Despite this, Zeotech and UQ expect to achieve a continuous closed-loop circuit in the near term. The completion of a successful continuous closed-loop circuit under the conditions of Zeotech's proprietary flowsheet, represents a major step in developing the configuration and design data required for scale-up to pilot line construction and commissioning, which is scheduled to commence First Quarter 2022. The focus for the remainder of 2021 is aimed at further optimisation of process steps targeted at achieving a continuous closed-loop circuit utilising Li process by-product. In addition, procurement of plant and equipment for the pilot line set-up has accelerated with key items scheduled for delivery early 2022. Reported Earnings • Sep 28
Full year 2021 earnings released: AU$0.002 loss per share (vs AU$0.003 loss in FY 2020) Full year 2021 results: Net loss: AU$2.92m (loss widened 5.9% from FY 2020). Over the last 3 years on average, earnings per share has increased by 20% per year but the company’s share price has increased by 103% per year, which means it is tracking significantly ahead of earnings growth. Anuncio • May 24
Zeotech Limited announced that it expects to receive AUD 3.7005 million in funding Zeotech Limited (ASX:ZEO) announced private placement of 52,864,286 shares at a price of AUD 0.07 per share for gross proceeds of AUD 3,700,500 on May 24, 2021. The transaction will include participation from sophisticated investors. The transaction has been approved by the board of directors of the company. The shares are expected to be issued on May 28, 2021. Reported Earnings • Mar 18
First half 2021 earnings released: AU$0.001 loss per share (vs AU$0.001 loss in 1H 2020) First half 2021 results: Net loss: AU$1.68m (loss widened 150% from 1H 2020). Over the last 3 years on average, earnings per share has increased by 44% per year but the company’s share price has increased by 87% per year, which means it is tracking significantly ahead of earnings growth. Anuncio • Feb 16
Zeotech Limited Pilot Plant Program Commences Zeotech Limited announce that it has committed to the development and construction of a pilot plant and is undertaking an extensive test-work- program to further optimise the flowsheet of the Company's low-cost synthetic zeolite manufacturing technology to de-risk future commercial investment. Following the positive outcomes of extensive lab-scale work undertaken by researchers from UQ, since lodging a core provisional patent application in June 2019, for the manufacture (synthesis) of synthetic zeolites from kaolin or clay-based materials i.e., mine tailings or process residues, Zeotech has committed to undertake a comprehensive pilot plant program. The program will incorporate an artificial intelligence (machine learning) component to enhance understanding and application of piloting results, by building a comprehensive dataset and predictive capabilities. The pilot plant will provide Zeotech with increased confidence and certainty on the engineered flowsheet design and operational performance of the process circuit before committing to commercial zeolite production facilities. Zeotech's decision to proceed with the pilot plant is supported by continued positive lab-scale results delivered by research funded at UQ and based on the understanding that a well designed and constructed pilot plant is an integral component in the decision-making process required to determine critical economics and underpin future commercial plant strategy and financing. The pilot plant should also demonstrate the efficiency of Zeotech's novel and proprietary mineral processing technology and proficiency of the process design by producing very high-grade material on a continuous, customer sample scale, basis. The program's aim is to commission pilot plant in the December Quarter 2021. The University of Queensland's Associate Professor James Vaughan and Dr. Hong (Marco) Peng from the School of Chemical Engineering will provide technical support for the pilot plant program's studies. Pilot Plant Funding: As announced on 5 January 2021, the Company raised $1.7 million to support funding of the pilot plant program. It is important to note that as the pilot plant research program revolves around validating Zeotech's patent-pending technology, it is classified as Research and Development and accordingly it will be eligible for the Australian Government's R&D tax incentive scheme. Zeotech targeting Type A zeolites: The Company's novel and proprietary mineral processing technology provides potential access to the AUD 2.6 billion global Type A zeolite market, with a focus on high value molecular sieve zeolites, which achieve prices in excess of AUD 2,850 per tonne. Anuncio • Feb 08
Zeotech Limited Executes Research Agreement with UQ to Evaluate Carbon Capture Using Synthetic Zeolites Zeotech Limited announced it has executed a dedicated research agreement with The University of Queensland ("UQ") to evaluate the performance of synthetic zeolites in the field of carbon capture, a market that is projected to reach USD 6.15 billion by 2027. Zeotech is assessing how to leverage its novel and proprietary mineral processing technology for the low-cost synthesis of synthetic zeolites to deliver economically feasible environmental management solutions for carbon capture. The carbon capture research program will commence 1 March 2021 and will be carried out over a nine-month period. The program will consist of the following stages: Characterisation of synthetic zeolites and commercial adsorbents - this will involve building a database of different types of the synthetic zeolites and commercial adsorbents, following their characterisation, and comparing properties; Carbon dioxide adsorption capacity and selectivity measurement - this will involve measuring and comparing the carbon dioxide (CO2) adsorption capacity of the synthetic zeolites and commercial adsorbents. The synthetic zeolites selectivity of CO2 over other gases such as N2 will also be investigated; and Granulation study of synthetic zeolite products - this will involve an agglomeration study of synthetic zeolites will be carried out in this stage. The preparation process of the synthetic zeolite agglomerate will be explored, and the carbon capture performance of these bulk adsorbents will be evaluated. Zeotech's carbon capture research program will also incorporate detailed economic analysis of: The use of different synthetic zeolites produced by Zeotech and the commercial adsorbents for carbon capture and selectivity; and Granulation of synthetic zeolite products and the commercial adsorbents for carbon capture and selectivity. Growing environmental concerns regarding global warming and climate change have motivated researchers to develop more efficient and improved processes for CO2 capture from large point sources of CO2. Adsorption processes using solid sorbents capable of capturing CO2 from flue gas streams have shown many potential advantages, compared to other conventional CO2 capture processes using aqueous amine solvents. Microporous crystalline framework materials such as synthetic zeolites are widely used in the field of gas separation and purification, commercially. Synthetic zeolites have shown promising results for separation of CO2 from gas streams and there is much published literature concerning CO2 adsorption over different types of zeolites. Zeotech's aim is to leverage the economic benefits of its synthetic zeolite mineral processing technology. For example, UQ's Chemical Engineering team has demonstrated up to 70% reduction in energy consumption in the thermal activation stage and up to 80% reduction in production time in the subsequent zeolite precipitation steps, in the synthesis of synthetic zeolites, coupled with the excellent structural properties of the synthetic zeolite to produce low-cost solid adsorbent for commercial CO2 capture to reduce greenhouse gases. Zeotech is also pleased to advise it continues to grow its in-house technical team, with the
employment of Mr. John Vogrin on a full-time basis. Mr. Vogrin is a PhD candidate (awaiting examination) and Alumina Quality Workshop scholar in the School of Chemical Engineering at The University of Queensland. He has recently submitted his thesis on the hydrothermal synthesis of zeolites in industrial processes such as the Bayer process and anion incorporation into their structure. John's expertise includes XRD (quantitative/qualitative), ICP, XRF, FE-SEM, TGA, PSD and UV-Raman spectroscopy for materials characterisation. His latest publication is 'Influence of Chloride on Sodium Aluminosilicate Solubility in Bayer Liquor'. He holds a Bachelor of Engineering (B.E.) in Chemical and Metallurgical Engineering (Honours). Anuncio • Jan 12
Zeotech Limited Announces resignation of John Goody as Non-Executive Director Zeotech Limited announced that Mr. John Goody has resigned as a non-executive director of the Company. Anuncio • Oct 05
Metalsearch Limited Announces Participating in Agronomic Trials to Evaluate the Performance of Synthetic Zeolites Across A Range of Agricultural Applications Metalsearch Limited announced it is participating in agronomic trials to evaluate the performance of synthetic zeolites across a range of agricultural applications. The trials will be undertaken in collaboration with Griffith University
and the University of Queensland. MSE is exploring the application of synthetic zeolites in the agricultural industry after being introduced to Griffith University by the University of Queensland, in order to link into an agronomic zeolite trial program to be conducted over the next 6-9 months. The program will consist of: Zeolite sorption and desorption experimentation; Agronomic performance testing via glasshouse pot trials, benchmarking against conventional soil amendment; Assessing plant growth performance under optimal water-availability and drought conditions; and Pesticide-destruction experiments - testing the photocatalytic oxidation potential of zeolites amended with commonly-encountered pesticides in Australian agriculture. MSE considers one of the inhibitors to the wider commercial adoption of synthetic zeolites in the agricultural sector has been the cost of production. The ability to produce low-cost synthetic zeolites from kaolin or suitable zero-cost mine waste streams using the University of Queensland's developed mineral processing technology enables MSE to tangibly investigate end-product strategies to exploit its patent-pending zeolite mineral processing technologies. Zeolites have a range of agricultural applications, such as; soil amendment i.e. improve water-holding capacity and aid fertilizer uptake; fertilizer additives i.e. aid slow-release; animal feed additives i.e. dietary supplement and mycotoxin adsorption; animal waste treatment i.e. increasing nitrogen retentivity and controlling moisture; and aquaculture i.e. remove ammonium, oxygen generation and as a feed supplement. Griffith University's agronomic zeolite trials will incorporate detailed economic analysis, which may potentially translate into a more intensive collaboration between Griffith University, the University of Queensland and MSE - the objective being to set the foundation for specialised synthetic zeolite Agri-product development studies. Anuncio • Jul 31
Metalsearch Limited announced that it has received AUD 1.6575 million in funding Laconia Resources Limited (ASX:LCR) a private placement of 127,500,000 common shares for AUD 0.013 per share for gross proceeds of AUD 1,657,500 on July 28, 2020. The transaction included participation from sophisticated investors.